Physician profile
Katrina E Muench
NPI 1578269296
$649.84
in general payments reported to CMS, 2019-2025
13 companies · $224 in 2025
The $224 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $101 · 2024: $325 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $649.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $253.67 | 2023-2025 | |
| Pfizer INC. | $91.83 | 2024-2025 | |
| Glaxosmithkline, LLC. | $59.33 | 2023-2024 | Bexsero, Trelegy Ellipta |
| Ironshore Pharmaceuticals INC. | $42.47 | 2024 | |
| Sumitomo Pharma America, INC. | $39.55 | 2023 | Myfembree |
| Hologic Sales and Service, LLC | $24.71 | 2024 | Thinprep 2000 Processor, Aptima |
| Lilly USA, LLC | $21.75 | 2024 | Zepbound, Mounjaro |
| Otsuka America Pharmaceutical, INC. | $21.36 | 2024 | Rexulti |
| Sobi, INC | $21.21 | 2023 | |
| Abbott Laboratories | $20.87 | 2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $18.67 | 2024 | |
| Merck Sharp & Dohme LLC | $18.30 | 2025 | Capvaxive |
| Amgen INC. | $16.12 | 2025 | Otezla, Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina Muench listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.